A Nursing Researcher’s Experience in a COVID-19 Vaccine Trial | Humanities | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
December 7, 2020

A Nursing Researcher’s Experience in a COVID-19 Vaccine Trial

Author Affiliations
  • 1School of Nursing, University of California, Los Angeles
  • 2Department of Health Policy & Management, Fielding School of Public Health, University of California, Los Angeles
JAMA Intern Med. 2021;181(2):157-158. doi:10.1001/jamainternmed.2020.7087

I was scrolling through Instagram in early August 2020 when I saw an advertisement that caught my attention. Usually, I swipe past these without a second glance, but this was for the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine trial. It was recruiting participants for the highly publicized phase 3 trial of a new vaccine, BNT162b2, that had shown promising results earlier in the year. As a nurse and researcher who has encountered social media recruitment in my own work—and has closely followed the COVID-19 vaccine trials—I was curious to see how Pfizer planned to convince 30 000 people in the US to volunteer. I clicked on the advertisement.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    Positive response to vaccine reactions
    James Dickinson, MBBS PhD | Department of Family Medicine, U Calgary, Alberta, Canada
    Patient response to vaccines depends on how we frame it. For the Herpes Zoster Vaccine, I warn patients that they may have a reaction, and that this is a positive since it shows that their immune system is responding as we want it to. Most patients take precautions, and have their vaccine before a day when they have no major plans. This way complaints are minimal.